+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies



Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies



Journal of Clinical Immunology 35(4): 361-365



Since we described for the first time a patient with IgG4 autoantibodies to IFN-γ more than 10 years ago, many patients with IFN-γ IgG4 autoantibodies have been described, mostly in Mongolian/ Asian patients with a particular HLA background and in association with disseminated nontuberculous mycobacterial infections. Very recently, the first Caucasian US patient was reported and we now present the case of a 65-year old Caucasian woman with severe disseminated Mycobacterium avium infection, cerebral toxoplasmosis and salmonella sepsis who was tested positive for IFN-γ deficiency due to unusual anti-IFN-γ IgG1 autoantibodies. IFN-γ production after ex vivo ConA stimulation of the patient's whole blood and isolated peripheral blood mononuclear cells was assessed. Anti-human IFN-γ antibodies were measured by Ig/Ig-subclass-specific ELISA. In vitro physiologic relevance and blocking capacity of IFN-γ-stimulation by patient's serum was analysed by flow cytometric assessment of cytokine-induced phosphorylation of pSTAT1(Y701). Severely impaired IFN-γ production in the patient's whole blood but normal production in peripheral blood mononuclear cells in the absence of autologous serum was observed. High titre anti-IFN-γ antibodies of the IgG1 subclass could be demonstrated in the patient's serum by ELISA. Further, the addition of patient's serum to IFN-γ-stimulated immune cells showed inhibition of STAT1 phosphorylation. IFN-γ autoantibodies of any IgG-isotype should be considered in patients with severe opportunistic infections independent of age at onset and ethnicity.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058201900

Download citation: RISBibTeXText

PMID: 25875701

DOI: 10.1007/s10875-015-0161-5


Related references

Disseminated Mycobacterium avium and recurrent Salmonella group D infection in a patient with autoantibodies to interferon-gamma. Southeast Asian Journal of Tropical Medicine and Public Health 44(3): 460-467, 2013

Recurrence of disseminated Mycobacterium avium complex disease in a patient with anti-gamma interferon autoantibodies by reinfection. Journal of Clinical Microbiology 53(4): 1436-1438, 2015

Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex. Journal of Infection and ChemoTherapy 15(2): 118-122, 2009

Disseminated Mycobacterium avium complex infection in a patient with autoantibody to interferon-gamma. Internal Medicine 46(13): 1005-1009, 2007

Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency. European Journal of Pediatrics 166(9): 981-985, 2007

Disseminated Mycobacterium avium -Intracellulare Complex Infection Presenting With Disseminated Intravascular Coagulation in an AIDS Patient. Journal of Investigative Medicine High Impact Case Reports 5(4): 2324709617740904, 2017

First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti-interferon-gamma autoantibodies. New Microbes and new Infections 27: 4-6, 2019

The first US domestic report of disseminated Mycobacterium avium complex and anti-interferon-γ autoantibodies. Journal of Clinical Immunology 34(8): 928-932, 2014

Effective combination therapy using interferon-gamma and interleukin-2 for disseminated Mycobacterium avium complex infection in a pediatric patient with AIDS. Clinical Infectious Diseases 41(11): E104-E106, 2005

Cerebral Mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated Mycobacterium avium complex infection. European Journal of Clinical Microbiology and Infectious Diseases 20(3): 199-201, 2001

Successful HLA-identical bone marrow transplantation in a patient with interferon-gamma receptor 2 deficiency and disseminated Mycobacterium avium complex infection. Journal of Allergy & Clinical Immunology 113(2 Suppl.): S44, 2004

Late cerebral relapse of a Mycobacterium avium complex disseminated infection in an HIV-infected patient after cessation of antiretroviral therapy. Aids 17(9): 1410-1411, 2003

Disseminated Mycobacterium avium Infection Presenting with Bladder Lesions in a Patient with Interferon-γ-neutralizing Autoantibodies. Internal Medicine 57(20): 3041-3045, 2018

Mycobacterium avium complex empyema in a patient with interferon gamma autoantibodies. Hawai'i Journal of Medicine and Public Health 73(9 Suppl 1): 15-17, 2014

Chronic pachymeningitis: Unusual manifestation of a Mycobacterium avium intracellulare complex infection in a nonimmunosuppressed patient. Aktuelle Neurologie 23(2): 78-81, 1996